Menu
Intsel Chimos has extensive knowledge of the French healthcare system, from early and compassionate access to Marketing Authorisation (MA) registration, in compliance with pharmaceutical regulations.
Thanks to its network of international partners, Intsel Chimos can respond quickly to hospitals’ inquiries for new treatments in a flexible and adaptable manner.
As a pharmaceutical company, Intsel Chimos is committed to proactively managing the different demands of its partners across all its activities.
The employees of Intsel Chimos are proud of their long experience in early markets access. They regularly operate in an ethical manner according to internal policies and in strict compliance with external regulations.
To assist our innovative pharmaceutical partners in bringing their medicines to market in the simplest and most efficient possible way.
To enable healthcare professionals to treat their patients suffering from rare and/or serious diseases.